| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
6 companies
Jean Jacques Bienaime is Director at BMRN and has filed Form 4s across 6 companies. From September 2015 to August 2026, the filings on record show 21 open-market purchases and 123 sales. Jean Jacques Bienaime's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $31.2M at current prices.
Historically, Jean Jacques Bienaime's trades have earned a middling insider score of 68/100 across 67 rated trades. Over a 12-month horizon, 64.3% of those trades were profitable, with an average 12-month return of +8.5%.
The biggest single holding is BMRN (~$26.4M) as Director. The BMRN filings lean toward selling, a net 2,115,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2016 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 41,666 | $91.49 | $3,811,868.18 | -9.9% | |
| Jul 18, 2016 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 41,666 | $92.72 | $3,863,271.52 | -9.9% | |
| Jun 16, 2016 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 41,666 | $80.55 | $3,356,196.30 | -9.9% | |
| Sep 10, 2015 | IMUX Immunic, Inc. | Director | Buy | 14,000 | $3.08 | $43,093.40 | +55.7% |